Literature DB >> 22742624

Sepsis studies need new direction.

Jonathan Cohen1, Steven Opal, Thierry Calandra.   

Abstract

Mesh：

Year:  2012        PMID： 22742624     DOI： 10.1016/S1473-3099(12)70136-6

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  57 in total

1.  MicroRNA 21 (miR-21) and miR-181b couple with NFI-A to generate myeloid-derived suppressor cells and promote immunosuppression in late sepsis.

Authors:  Clara McClure; Laura Brudecki; Donald A Ferguson; Zhi Q Yao; Jonathan P Moorman; Charles E McCall; Mohamed El Gazzar
Journal:  Infect Immun       Date:  2014-06-30       Impact factor: 3.441

2.  Frontline Science: Monocytes sequentially rewire metabolism and bioenergetics during an acute inflammatory response.

Authors:  Xuewei Zhu; Allison Meyers; David Long; Brian Ingram; Tiefu Liu; Barbara K Yoza; Vidula Vachharajani; Charles E McCall
Journal:  J Leukoc Biol       Date:  2019-01-11       Impact factor: 4.962

3.  Immunology. Getting sepsis therapy right.

Authors:  Richard S Hotchkiss; Edward R Sherwood
Journal:  Science       Date:  2015-03-13       Impact factor: 47.728

Review 4.  Neural pathways involved in infection-induced inflammation: recent insights and clinical implications.

Authors:  Marion Griton; Jan Pieter Konsman
Journal:  Clin Auton Res       Date:  2018-03-14       Impact factor: 4.435

Review 5.  Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach.

Authors:  Richard S Hotchkiss; Guillaume Monneret; Didier Payen
Journal:  Lancet Infect Dis       Date:  2013-03       Impact factor: 25.071

Review 6.  Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression.

Authors:  Naeem K Patil; Julia K Bohannon; Edward R Sherwood
Journal:  Pharmacol Res       Date:  2016-07-25       Impact factor: 7.658

7.  NFI-A disrupts myeloid cell differentiation and maturation in septic mice.

Authors:  Clara McClure; Ekram Ali; Dima Youssef; Zhi Q Yao; Charles E McCall; Mohamed El Gazzar
Journal:  J Leukoc Biol       Date:  2015-08-10       Impact factor: 4.962

8.  T helper type 2-polarized invariant natural killer T cells reduce disease severity in acute intra-abdominal sepsis.

Authors:  R V Anantha; D M Mazzuca; S X Xu; S A Porcelli; D D Fraser; C M Martin; I Welch; T Mele; S M M Haeryfar; J K McCormick
Journal:  Clin Exp Immunol       Date:  2014-11       Impact factor: 4.330

Review 9.  Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.

Authors:  Richard S Hotchkiss; Guillaume Monneret; Didier Payen
Journal:  Nat Rev Immunol       Date:  2013-11-15       Impact factor: 53.106

10.  Heterogeneous models for an early discrimination between sepsis and non-infective SIRS in medical ward patients: a pilot study.

Authors:  Filippo Mearelli; Nicola Fiotti; Nicola Altamura; Michela Zanetti; Giovanni Fernandes; Ismet Burekovic; Alessandro Occhipinti; Daniele Orso; Carlo Giansante; Chiara Casarsa; Gianni Biolo
Journal:  Intern Emerg Med       Date:  2013-12-22       Impact factor: 3.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.